Theranostic Science Development with NMR/MRI/Radioligand Study; A Call for Collaborative Research in Target Delivery
  • Author(s): Taiwo Temitope Philip
  • Paper ID: 1715278
  • Page: 3546-3548
  • Published Date: 30-04-2026
  • Published In: Iconic Research And Engineering Journals
  • Publisher: IRE Journals
  • e-ISSN: 2456-8880
  • Volume/Issue: Volume 9 Issue 9 March-2026
Abstract

There has been a wide spread in the cases of cancer in the recent decades with different types of cancers emerging every decade (Yang et al, 2018), management has evolved from great study with the discovery of chemotherapeutic agents. However, the adverse effects from these chemotherapeutic agents and chemotherapy (irradiation) have pointed the needs for more targeted drug discovery. In the last decades, development of targeted drug delivery via monoclonal antibodies and others has helped sharpen the management of cancer.

Citations

IRE Journals:
Taiwo Temitope Philip "Theranostic Science Development with NMR/MRI/Radioligand Study; A Call for Collaborative Research in Target Delivery" Iconic Research And Engineering Journals Volume 9 Issue 9 2026 Page 3546-3548 https://doi.org/10.64388/IREV9I9-1715278

IEEE:
Taiwo Temitope Philip "Theranostic Science Development with NMR/MRI/Radioligand Study; A Call for Collaborative Research in Target Delivery" Iconic Research And Engineering Journals, 9(9) https://doi.org/10.64388/IREV9I9-1715278